Dec 12, 2025 08:44AM
Nov 13, 2025 04:46AM
Nov 12, 2025 07:30AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM
Aug 13, 2025 07:30AM
May 27, 2025 08:01AM XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
May 13, 2025 07:30AM
Mar 17, 2025 04:30PM
Feb 25, 2025 07:27AM
Jan 8, 2025 09:28AM
Nov 7, 2024 07:30AM
Sep 23, 2024 06:38AM
Sep 23, 2024 06:31AM XOMA (XOMA) Announces FDA Approval of MIPLYFFA for Patients with Niemann-Pick Disease Type C
Sep 23, 2024 06:30AM
Aug 13, 2024 07:30AM
May 9, 2024 07:30AM
Apr 30, 2024 07:30AM
Apr 25, 2024 07:30AM
Apr 25, 2024 07:30AM
Mar 8, 2024 07:30AM XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
Jan 18, 2024 08:33AM
Jan 18, 2024 08:30AM
Jan 11, 2024 04:05PM
Jan 9, 2024 08:00AM
Nov 7, 2023 07:30AM
Oct 31, 2023 07:30AM
Oct 31, 2023 07:30AM XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Jun 22, 2023 07:30AM
Jun 22, 2023 07:30AM
Jun 22, 2023 07:30AM
May 5, 2022 07:30AM
Mar 8, 2022 07:30AM
Dec 16, 2021 07:30AM
Nov 4, 2021 07:42AM XOMA (XOMA) Announces $35M Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Trial
Nov 4, 2021 07:40AM
Nov 4, 2021 07:30AM
Aug 5, 2021 07:30AM
Jul 28, 2021 07:35AM
Jul 28, 2021 07:30AM
Jul 15, 2021 06:15AM
Jul 15, 2021 04:00AM XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Biosciences
Apr 15, 2021 09:09AM
Apr 15, 2021 09:05AM
Mar 10, 2021 07:30AM
Aug 6, 2019 07:30AM
Jul 4, 2019 07:05AM
Oct 30, 2018 08:05AM
Aug 25, 2017 09:10AM Pre-Open Stock Movers 08/25: (ADMS) (XOMA) (KMDA) Higher; (GME) (ULTA) (VEEV) Lower (more...)

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All